JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ATEK
3376
DELISTED
Athena Technology Acquisition Corp. II
ATEK
| $2.01M | ﹤0.01% |
+200,000
| New | +$2M |
2022 Q4
0 quarters
|
|
|
SCU
3377
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $2.01M | ﹤0.01% |
232,242
+26,173
| +13% | +$251K |
2013 Q2
38 quarters
|
|
|
FRSG
3378
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
| $2.01M | ﹤0.01% |
200,000
-50,000
| -20% | -$497K |
2022 Q1
3 quarters
|
|
3379
PUT
LyondellBasell Industries
LYB
$18.8B
| $2.01M | ﹤0.01% |
24,200
-11,000
| -31% | -$901K |
2022 Q1
3 quarters
|
|
3380
Resources Connection
RGP
$128M
| $2.01M | ﹤0.01% |
109,140
+37,050
| +51% | +$681K |
2013 Q2
38 quarters
|
|
|
TPBA
3381
DELISTED
TPB Acquisition Corporation I Class A Ordinary Share
TPBA
| $2.01M | ﹤0.01% |
199,900
-100
| -0.1% | -$992 |
2022 Q3
1 quarter
|
|
3382
CALL
D.R. Horton
DHI
$37.2B
| $2.01M | ﹤0.01% |
22,500
| – | – |
2021 Q1
7 quarters
|
|
3383
CALL
Innoviz Technologies
INVZ
$94M
| $2M | ﹤0.01% |
+510,000
| New | +$2.43M |
2022 Q4
0 quarters
|
|
3384
PUT
Teladoc Health
TDOC
$1.01B
| $2M | ﹤0.01% |
+84,700
| New | +$2.28M |
2022 Q4
0 quarters
|
|
|
3385
CALL
Exelon
EXC
$42.9B
| $2M | ﹤0.01% |
46,300
| – | – |
2021 Q1
7 quarters
|
|
3386
MakeMyTrip
MMYT
$4.04B
| $2M | ﹤0.01% |
72,589
-4,040
| -5% | -$117K |
2021 Q3
5 quarters
|
|
3387
iShares Core US REIT ETF
USRT
$4.25B
| $2M | ﹤0.01% |
40,419
+37,184
| +1,149% | +$1.84M |
2018 Q4
16 quarters
|
|
3388
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$251M
| $2M | ﹤0.01% |
+1,166
| New | +$2.73M |
2022 Q4
0 quarters
|
|
3389
International Seaways
INSW
$5.85B
| $2M | ﹤0.01% |
53,972
-34,886
| -39% | -$1.41M |
2016 Q4
24 quarters
|
|
3390
State Street Nuveen Municipal Bond ETF
MBND
$25.7M
| $2M | ﹤0.01% |
74,695
| – | – |
2021 Q1
7 quarters
|
|
|
KNBE
3391
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $1.99M | ﹤0.01% |
80,482
+40,359
| +101% | +$983K |
2021 Q3
5 quarters
|
|
3392
Warby Parker
WRBY
$3.15B
| $1.99M | ﹤0.01% |
147,738
+9,955
| +7% | +$152K |
2021 Q3
5 quarters
|
|
3393
Keros Therapeutics
KROS
$223M
| $1.99M | ﹤0.01% |
41,481
+23,710
| +133% | +$1.11M |
2020 Q2
10 quarters
|
|
3394
Gossamer Bio
GOSS
$64.3M
| $1.99M | ﹤0.01% |
11,470
+10,561
| +1,162% | +$6.96M |
2019 Q1
15 quarters
|
|
3395
CALL
XPeng
XPEV
$9.14B
| $1.99M | ﹤0.01% |
+200,200
| New | +$1.8M |
2022 Q4
0 quarters
|
|
3396
Lyell Immunopharma
LYEL
$214M
| $1.99M | ﹤0.01% |
28,607
+2,607
| +10% | +$259K |
2021 Q3
5 quarters
|
|
|
CNDA
3397
DELISTED
Concord Acquisition Corp II
CNDA
| $1.98M | ﹤0.01% |
199,500
-55,500
| -22% | -$545K |
2021 Q4
4 quarters
|
|
3398
Luxfer Holdings
LXFR
$466M
| $1.98M | ﹤0.01% |
144,541
+123,934
| +601% | +$1.81M |
2016 Q1
27 quarters
|
|
3399
CALL
Marathon Petroleum
MPC
$124B
| $1.98M | ﹤0.01% |
17,000
+3,300
| +24% | +$376K |
2021 Q1
7 quarters
|
|
3400
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.32B
| $1.98M | ﹤0.01% |
21,257
+1,593
| +8% | +$147K |
2020 Q3
9 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.